Medical treatment of juvenile hemangiomas;Traitement médical des hémangiomes immatures

Annales de Chirurgie Plastique Esthetique

Volumn 51, Issue 4-5, 2006, Pages 310-320

  Boon, L M ^a   Bataille, A C ^a   Bernier, V ^a   Vermylen, C ^a   Verellen, G ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Bleomycin; Corticotherapy; Hemangioma; Interferon; Laser; Radiotherapy; Vincristine

Indexed keywords

ALPHA2A INTERFERON; BLEOMYCIN; CLOBETASOL PROPIONATE; CORTICOSTEROID; CORTISONE; CYCLOPHOSPHAMIDE; PREDNISOLONE; TRIAMCINOLONE ACETONIDE; VINCRISTINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANGIOGENESIS; ARTICLE; ARTIFICIAL EMBOLISM; CANCER RADIOTHERAPY; CRYOTHERAPY; DEPRESSION; DISEASE ASSOCIATION; HEMANGIOMA; HUMAN; HYPOTHYROIDISM; LASER; NEUROTOXICITY; NEUTROPENIA; OUTCOME ASSESSMENT; RISK ASSESSMENT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 33749659480     PISSN: 02941260     EISSN: 1768319X     Source Type: Journal    
DOI: 10.1016/j.anplas.2006.07.004     Document Type: Article

References (54)

1. Mason K.P., Koka B.V., Eldredge E.A., Fishman S.J., and Burrows P.E. Perioperative considerations in a hypothyroid infant with hepatic haemangioma. Paediatr. Anaesth. 11 (2001) 228-232
2. Tanner J.L., Dechert M.P., and Frieden I.J. Growing up with a facial hemangioma: parent and child coping and adaptation. Pediatrics 101 (1998) 446-452
3. Costello M.J. Management of vascular nevi. Pediatrics 4 (1949) 825-832
4. Mac Collum D.W., and Martin L.W. Hemangiomas in infancy and childhood: a report based on 6479 cases. Surg. Clin. North Amer. 36 (1956) 1647-1663
5. Matthews D.N. Treatment of hemangiomata. Br. J. Plast. Surg. 6 (1953) 83
6. Underwood GBaG L.E. Disfiguring sequelae from radium therapy: result of treatment of a birthmark adjacent to the breast in a female infant. A.M.A. Arch. Dermat. 57 (1948) 918
7. Burrows P.E., and Fellows K.E. Techniques for management of pediatric vascular anomalies. In: Cope C. (Ed). Current Techniques in interventional radiology (1995), Current Medicine, Philadelphia 11-27
8. Hasan Q., Tan S.T., Gush J., Peters S.G., and Davis P.F. Steroid therapy of a proliferating hemangioma: histochemical and molecular changes. Pediatrics 105 (2000) 117-120
9. Mulliken J.B., Boon L.M., Takahashi K., Ohlms L.A., Folkman J., and Ezekowiz R.A.B. Pharmacologic therapy for endangering hemangiomas. Current Opinion Dermatol. (1995) 109-113
10. Bennett M.L., Fleischer A.B.J., Chamlin S.L., and Frieden I.J. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch. Dermatol. 137 (2001) 1208-1213
11. Enjolras O., Riche M.C., Merland J.J., and Escande J.P. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 85 (1990) 491-498 [see comments]
12. Sadan N., and Wolach B. Treatment of hemangiomas of infants with high doses of prednisone. J. Pediatr. 128 (1996) 141-146
13. Pokorny J.J., Roth F., Balfour I., and Rinehart G. An unusual complication of the treatment of a hemangioma. Ann. Plast. Surg. 48 (2002) 83-87
14. Boon L.M., MacDonald D.M., and Mulliken J.B. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast. Reconstr. Surg. 104 (1999) 1616-1623
15. Sheu B.C., Shyu M.K., Lin Y.F., et al. Prenatal diagnosis and corticosteroid treatment of diffuse neonatal hemangiomatosis: case report. J. Ultrasound Med. 13 (1994) 495-499
16. Mejides A.A., Adra A.M., O'Sullivan M.J., and Nicholas M.C. Prenatal diagnosis and therapy for a fetal hepatic vascular malformation. Obstet. Gynecol. 85 (1995) 850-853
17. Morris J., Abbott J., Burrows P., and Levine D. Antenatal diagnosis of fetal hepatic hemangioma treated with maternal corticosteroids. Obstet. Gynecol. 94 (1999) 813-815
18. Chen M.T., Yeong E.K., and Horng S.Y. Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: a review of 155 cases. J. Pediatr. Surg. 35 (2000) 420-423
19. Kushner B.J. The treatment of periorbital infantile hemangioma with intralesional corticosteroid. Plast. Reconstr. Surg. 76 (1985) 517-526
20. Shorr N., and Seiff S.R. Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile hemangioma. Ophthalmic Surg. 17 (1986) 229-231
21. Mulliken J.B. Vascular anomalies. In: Sherrell J.A., Robert W.B., and Charles H.M.T. (Eds). Grabb and Smith's Plastic Surgery (1997), Lippincott-Raven, Philadelphia, PA 191-203
22. Sloan G.M., Reinisch J.F., Nichter L.S., Saber W.L., Lew K., and Morwood D.T. Intralesional corticosteroid therapy for infantile hemangiomas. Plast. Reconstr. Surg. 83 (1989) 459-467
23. Elsas F.J., and Lewis A.R. Topical treatment of periocular capillary hemangioma. J. Pediatr. Ophthalmol. Strabismus 31 (1994) 153-156
24. Cruz O.A., Zarnegar S.R., and Myers S.E. Treatment of periocular capillary hemangioma with topical clobetasol propionate. Ophthalmology 102 (1995) 2012-2015
25. Ezekowitz R.A., Mulliken J.B., and Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N. Engl. J. Med. 326 (1992) 1456-1463
26. Blei F., Orlow S.J., and Geronemus R.G. Interferon alfa-2a therapy for extensive perianal and lower extremity hemangioma. J. Am. Acad. Dermatol. 29 (1993) 98-99
27. Boon L.M., Burrows P.E., Paltiel H.J., et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J. Pediatr. 129 (1996) 346-354
28. Chang E., Boyd A., Nelson C.C., et al. Successful treatment of infantile hemangiomas with interferon-alpha-2b. J. Pediatr. Hematol. Oncol. 19 (1997) 237-244
29. Isik F.F., Rand R.P., Gruss J.S., Benjamin D., and Alpers C.E. Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations. J. Surg. Res. 61 (1996) 71-76
30. Miller J.W., Stinson W.G., and Folkman J. Regression of experimental iris neovascularization with systemic alpha- interferon. Ophthalmology 100 (1993) 9-14
31. Ohlms L.A., Jones D.T., McGill T.J., and Healy G.B. Interferon alfa-2a therapy for airway hemangiomas. Ann. Otol. Rhinol. Laryngol. 103 (1994) 1-8
32. Hastings M.M., Milot J., Barsoum-Homsy M., Hershon L., Dubois J., and Leclerc J.M. Recombinant interferon alfa-2b in the treatment of vision-threatening capillary hemangiomas in childhood. J. AAPOS 1 (1997) 226-230
33. Barlow C.F., Priebe C.J., Mulliken J.B., et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J. Pediatr. 132 (1998) 527-530
34. Sarihan H., Mocan H., Yildiz K., Abes M., and Akyazici R. A new treatment with bleomycin for complicated cutaneous hemangioma in children. Eur. J. Pediatr. Surg. 7 (1997) 158-162
35. Perez-Payarols J., Pardo-Masferrer J., and Gomez-Bellvert C. Treatment of life-threatening infantile hemangiomas with vincristine. N. Engl. J. Med. 333 (1995) 69
36. Klement G., Baruchel S., Rak J., et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J. Clin. Invest. 105 (2000) R15-R24
37. Hurwitz R.L., Mahoney Jr. D.H., Armstrong D.L., and Browder T.M. Reversible encephalopathy and seizures as a result of conventional vincristine administration. Med. Pediatr. Oncol. 16 (1988) 216-219
38. Perez J., Pardo J., and Gomez C. Vincristine--an effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncol. 41 (2002) 197-199
39. Moore J., Lee M., Garzon M., et al. Effective therapy of a vascular tumor of infancy with vincristine. J. Pediatr. Surg. 36 (2001) 1273-1276
40. Haisley-Royster C., Enjolras O., Frieden I.J., et al. Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine. J. Pediatr. Hematol. Oncol. 24 (2002) 459-462
41. Enjolras O., Breviere G.M., Roger G., et al. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch. Pediatr. 11 (2004) 99-107
42. Garden J.M., Polla L.L., and Tan O.T. The treatment of port-wine stains by the pulsed dye laser. Analysis of pulse duration and long-term therapy. Arch. Dermatol. 124 (1988) 889-896
43. Tan O.T., Sherwood K., and Gilchrest B.A. Treatment of children with port-wine stains using the flashlamp-pulsed tunable dye laser. N. Engl. J. Med. 320 (1989) 416-421
44. Morelli J.G., Tan O.T., and Weston W.L. Treatment of ulcerated hemangiomas with the pulsed tunable dye laser. Am. J. Dis. Child. 145 (1991) 1062-1064
45. Mulliken J.B. A plea for a biologic approach to hemangiomas of infancy. Arch. Dermatol. 127 (1991) 243-244
46. Garden J.M., Bakus A.D., and Paller A.S. Treatment of cutaneous hemangiomas by the flashlamp-pumped pulsed dye laser: prospective analysis. J. Pediatr. 120 (1992) 555-560
47. Landthaler M., Hohenleutner U., and el-Raheem T.A. Laser therapy of childhood haemangiomas. Br. J. Dermatol. 133 (1995) 275-281
48. Scheepers J.H., and Quaba A.A. Does the pulsed tunable dye laser have a role in the management of infantile hemangiomas? Observations based on 3 years' experience. Plast. Reconstr. Surg. 95 (1995) 305-312
49. Haywood R.M., Monk B.E., and Mahaffey P.J. The treatment of early cutaneous capillary haemangiomata (strawberry naevi) with the tunable dye laser. Br. J. Plast. Surg. 53 (2000) 302-307
50. Batta K., Goodyear H.M., Moss C., Williams H.C., Hiller L., and Waters R. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet 360 (2002) 521-527
51. Achauer B.M., Celikoz B., and VanderKam V.M. Intralesional bare fiber laser treatment of hemangioma of infancy. Plast. Reconstr. Surg. 101 (1998) 1212-1217
52. Berlien H.P., Waldschimdt J., and Müller G. Laser treatment of cutaneous and deep vessel anomalies. In: Waidelich WaW R. (Ed). Laser optoelectronics in medicine (1988), Springer-Verlag, Berlin
53. Burstein F.D., Simms C., Cohen S.R., Williams J.K., and Paschal M. Intralesional laser therapy of extensive hemangiomas in 100 consecutive pediatric patients. Ann. Plast. Surg. 44 (2000) 188-194
54. Metz B.J., Rubenstein M.C., Levy M.L., and Metry D.W. Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor. Arch. Dermatol. 140 (2004) 867-870